Mata Nathan L.
Chief Scientific Officer at BLTE
- Sold, on record
- $2.7M
- Dollars the filings state
- Form 4 sales
- 17
- Latest May 7, 2026
- Form 144 notices
- 8
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BLTEBELITE BIO, INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BLTERoutineApr 28, 2026 2026
Sold 1,000 shares at $159.16 ($159k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 13% of holdings ($1.2M position)6,666 shares left1x usual sizeFollows a Form 144Filing
- 2 Form 4 sale BLTERoutineApr 29, 2026 +1 day
Sold 1,000 shares at $155.82 ($156k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 15% of holdings ($1M position)5,666 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 4 sale BLTERoutineApr 30, 2026 +1 day
Sold 1,000 shares at $156.97 ($157k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 17.6% of holdings ($889k position)4,666 shares left1x usual sizeFollows a Form 144Filing
- 4 Form 4 sale BLTERoutineMay 1, 2026 +1 day
Sold 1,000 shares at $155.78 ($156k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 21.4% of holdings ($727k position)3,666 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 4 sale BLTERoutineMay 4, 2026 +3 days
Sold 1,000 shares at $155.64 ($156k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 27.3% of holdings ($571k position)2,666 shares left1x usual sizeFollows a Form 144Filing
- 6 Form 4 sale BLTERoutineMay 5, 2026 +1 day
Sold 1,000 shares at $155.50 ($156k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 37.5% of holdings ($415k position)1,666 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 4 sale BLTERoutineMay 6, 2026 +1 day
Sold 1,000 shares at $153.84 ($154k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 60% of holdings ($256k position)666 shares left1x usual sizeFollows a Form 144Filing
- 8 Form 4 sale BLTERoutineMay 7, 2026 +1 day
Sold 666 shares at $153.21 ($102k)
Mata Nathan L., Chief Scientific Officer
10b5-1 planSold 100% of holdings ($102k position)0 shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 8, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 666 | $102k | 100.0% | Routine | SEC |
| May 6, 2026 | May 7, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $154k | 60.0% | Routine | SEC |
| May 5, 2026 | May 6, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $156k | 37.5% | Routine | SEC |
| May 4, 2026 | May 5, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $156k | 27.3% | Routine | SEC |
| May 1, 2026 | May 4, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $156k | 21.4% | Routine | SEC |
| Apr 30, 2026 | May 1, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $157k | 17.6% | Routine | SEC |
| Apr 29, 2026 | Apr 30, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $156k | 15.0% | Routine | SEC |
| Apr 28, 2026 | Apr 29, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $159k | 13.0% | Routine | SEC |
| Apr 27, 2026 | Apr 28, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $163k | 11.5% | Routine | SEC |
| Apr 24, 2026 | Apr 27, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $160k | 10.3% | Routine | SEC |
| Apr 23, 2026 | Apr 24, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $166k | 9.4% | Routine | SEC |
| Apr 22, 2026 | Apr 23, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $170k | 8.6% | Routine | SEC |
| Apr 21, 2026 | Apr 22, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $166k | 7.9% | Routine | SEC |
| Apr 20, 2026 | Apr 21, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $164k | 7.3% | Routine | SEC |
| Apr 17, 2026 | Apr 20, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $162k | 6.8% | Routine | SEC |
| Apr 16, 2026 | Apr 20, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $160k | 6.4% | Routine | SEC |
| Apr 15, 2026 | Apr 16, 2026 | BLTE | Chief Scientific Officer | Form 4 sale | 1,000 | $168k | 6.0% | Routine | SEC |
| Apr 15, 2026 | Apr 15, 2026 | BLTE | Officer | Form 144 notice | 16,666 | $2.9M | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | BLTE | Officer | Form 144 notice | 30,000 | $1.9M | Notice | SEC | |
| Mar 19, 2025 | Mar 19, 2025 | BLTE | Affiliate | Form 144 notice | 30,166 | $2M | Notice | SEC | |
| Nov 19, 2024 | Nov 19, 2024 | BLTE | Affiliate | Form 144 notice | 30,000 | $2.5M | Notice | SEC | |
| Aug 16, 2024 | Aug 16, 2024 | BLTE | affiliate | Form 144 notice | 30,000 | $15M | Notice | SEC | |
| Jun 4, 2024 | Jun 4, 2024 | BLTE | affiliate | Form 144 notice | 30,000 | $1.5M | Notice | SEC | |
| May 17, 2024 | May 17, 2024 | BLTE | Affiliate | Form 144 notice | 15,000 | $641k | Notice | SEC | |
| Mar 14, 2024 | Mar 14, 2024 | BLTE | Affiliate | Form 144 notice | 6,000 | $230k | Notice | SEC |